Ehsan Ghorani

5.0k total citations · 1 hit paper
31 papers, 1.3k citations indexed

About

Ehsan Ghorani is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Ehsan Ghorani has authored 31 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Public Health, Environmental and Occupational Health and 10 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Ehsan Ghorani's work include Gestational Trophoblastic Disease Studies (12 papers), Prenatal Screening and Diagnostics (8 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Ehsan Ghorani is often cited by papers focused on Gestational Trophoblastic Disease Studies (12 papers), Prenatal Screening and Diagnostics (8 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Ehsan Ghorani collaborates with scholars based in United Kingdom, United States and Canada. Ehsan Ghorani's co-authors include Carla P. Martins, Matthew A. Lakins, Hafsa Munir, Jacqueline D. Shields, Sergio A. Quezada, Charles Swanton, Michael J. Seckl, Neil J. Sebire, Andrew J.S. Furness and Long Jiao and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Immunity.

In The Last Decade

Ehsan Ghorani

30 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cancer-associated fibroblasts induce antigen-specific deletion of CD8 + T Cells to protect tumour cells

2018 437 citations Matthew A. Lakins, Ehsan Ghorani et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ehsan Ghorani United Kingdom	14	731	534	431	222	188	31	1.3k
Uta Oelschlägel Germany	22	488 0.7×	635 1.2×	428 1.0×	122 0.5×	254 1.4×	53	1.8k
Camilla Fröhlich Denmark	17	477 0.7×	175 0.3×	466 1.1×	194 0.9×	77 0.4×	22	1.1k
Janet Ayello United States	21	705 1.0×	529 1.0×	368 0.9×	74 0.3×	102 0.5×	117	1.3k
Anna Guarini Italy	28	853 1.2×	1.4k 2.7×	441 1.0×	160 0.7×	454 2.4×	90	2.6k
Philipp A. Greif Germany	19	387 0.5×	196 0.4×	718 1.7×	215 1.0×	227 1.2×	59	1.4k
Manoj Raghavan United Kingdom	17	257 0.4×	259 0.5×	734 1.7×	267 1.2×	308 1.6×	45	1.7k
Naotake Tanaka Japan	18	377 0.5×	119 0.2×	539 1.3×	163 0.7×	264 1.4×	55	1.4k
Antonia Busse Germany	19	567 0.8×	461 0.9×	495 1.1×	106 0.5×	103 0.5×	54	1.1k
Stephanie Sasse Germany	23	819 1.1×	624 1.2×	249 0.6×	61 0.3×	76 0.4×	48	1.6k
Mark Klinger United States	18	696 1.0×	872 1.6×	504 1.2×	200 0.9×	145 0.8×	30	1.7k

Countries citing papers authored by Ehsan Ghorani

Since Specialization

Citations

This map shows the geographic impact of Ehsan Ghorani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ehsan Ghorani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ehsan Ghorani more than expected).

Fields of papers citing papers by Ehsan Ghorani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ehsan Ghorani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ehsan Ghorani. The network helps show where Ehsan Ghorani may publish in the future.

Co-authorship network of co-authors of Ehsan Ghorani

This figure shows the co-authorship network connecting the top 25 collaborators of Ehsan Ghorani. A scholar is included among the top collaborators of Ehsan Ghorani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ehsan Ghorani. Ehsan Ghorani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Seckl, Michael J., Baljeet Kaur, Ehsan Ghorani, Alice Bergamini, & Giorgia Mangili. (2025). Controversies in malignant ovarian germ cell tumors. International Journal of Gynecological Cancer. 35(3). 101670–101670. 1 indexed citations

Ghorani, Ehsan & Michael J. Seckl. (2024). Future Directions for Gestational Trophoblastic Disease. Hematology/Oncology Clinics of North America. 38(6). 1265–1276. 4 indexed citations

Ghorani, Ehsan, Charles Swanton, & Sergio A. Quezada. (2023). Cancer cell-intrinsic mechanisms driving acquired immune tolerance. Immunity. 56(10). 2270–2295. 51 indexed citations

Ghorani, Ehsan, Matteo Quartagno, Fiona Blackhall, et al.. (2023). REFINE-Lung implements a novel multi-arm randomised trial design to address possible immunotherapy overtreatment. The Lancet Oncology. 24(5). e219–e227. 13 indexed citations

Baas, Inge O., et al.. (2023). Immunotherapy for Gestational Trophoblastic Neoplasia: A New Paradigm. Gynecologic and Obstetric Investigation. 89(3). 230–238. 14 indexed citations

Maher, Geoffrey J., Rosemary A. Fisher, Baljeet Kaur, et al.. (2022). Sensitive screening of single nucleotide polymorphisms in cell free DNA for diagnosis of gestational tumours. npj Genomic Medicine. 7(1). 26–26. 6 indexed citations

Nankivell, Matthew, Matteo Quartagno, Caroline S. Clarke, et al.. (2022). REFINE (REduced Frequency ImmuNE checkpoint inhibition in cancers): A multi-arm phase II basket trial testing reduced intensity immunotherapy across different cancers. Contemporary Clinical Trials. 124. 107030–107030. 12 indexed citations

Porter, Arthur T., John M. Moriarty, Jianyu Rao, et al.. (2021). Treatment of metastatic placental site trophoblastic tumor with surgery, chemotherapy, immunotherapy and coil embolization of multiple pulmonary arteriovenous fistulate. Gynecologic Oncology Reports. 36. 100782–100782. 7 indexed citations

Seckl, Michael J. & Ehsan Ghorani. (2021). Progress to international harmonisation of care and future developments. Best Practice & Research Clinical Obstetrics & Gynaecology. 74. 159–167. 5 indexed citations

10.

Al‐Rasheed, Nouf M., Lydia Lee, Ehsan Ghorani, et al.. (2020). Marrow-Infiltrating Regulatory T Cells Correlate with the Presence of Dysfunctional CD4+PD-1+ Cells and Inferior Survival in Patients with Newly Diagnosed Multiple Myeloma. Clinical Cancer Research. 26(13). 3443–3454. 50 indexed citations

11.

Bouchard‐Fortier, Geneviève, Ehsan Ghorani, Dee Short, et al.. (2020). Following chemotherapy for gestational trophoblastic neoplasia, do residual lung lesions increase the risk of relapse?. Gynecologic Oncology. 158(3). 698–701. 7 indexed citations

12.

Gálvez‐Cancino, Felipe, Ehsan Ghorani, Ernesto López, et al.. (2019). Tissue-resident memory CD8+ T cells amplify anti-tumor immunity by triggering antigen spreading through dendritic cells. Nature Communications. 10(1). 4401–4401. 162 indexed citations

13.

Balachandran, K., Abdulazeez Salawu, Ehsan Ghorani, et al.. (2019). When to stop human chorionic gonadotrophin (hCG) surveillance after treatment with chemotherapy for gestational trophoblastic neoplasia (GTN): A national analysis on over 4,000 patients. Gynecologic Oncology. 155(1). 8–12. 33 indexed citations

14.

Wang, Tengyao, Ehsan Ghorani, Simon Harper, et al.. (2019). A rational approach to postoperative surveillance for resected non-functional pancreatic neuro-endocrine tumours. Pancreatology. 19(7). 1000–1007. 3 indexed citations

15.

Ghorani, Ehsan, Simon Harper, Asif Jah, et al.. (2018). Lymph node ratio predicts recurrence following resections of non-functional pancreatic neuro-endocrine tumours (NF-PNET): a rational approach to postoperative surveillance. HPB. 20. S671–S672. 1 indexed citations

16.

Chakravarthy, Ankur, Andrew J.S. Furness, Kroopa Joshi, et al.. (2018). Pan-cancer deconvolution of tumour composition using DNA methylation. Nature Communications. 9(1). 3220–3220. 195 indexed citations

17.

Lakins, Matthew A., Ehsan Ghorani, Hafsa Munir, Carla P. Martins, & Jacqueline D. Shields. (2018). Cancer-associated fibroblasts induce antigen-specific deletion of CD8 + T Cells to protect tumour cells. Nature Communications. 9(1). 948–948. 437 indexed citations breakdown →

18.

Ghorani, Ehsan, Rachel Rosenthal, Nicholas McGranahan, et al.. (2017). Differential binding affinity of mutated peptides for MHC class I is a predictor of survival in advanced lung cancer and melanoma. Annals of Oncology. 29(1). 271–279. 96 indexed citations

19.

Jiao, Long, Ehsan Ghorani, Neil J. Sebire, & Michael J. Seckl. (2016). Intraplacental choriocarcinoma: Systematic review and management guidance. Gynecologic Oncology. 141(3). 624–631. 67 indexed citations

20.

Linker, Claudia, Costis Papanayotou, Ehsan Ghorani, et al.. (2009). Cell communication with the neural plate is required for induction of neural markers by BMP inhibition: evidence for homeogenetic induction and implications for Xenopus animal cap and chick explant assays. Developmental Biology. 327(2). 478–486. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact